Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Medications

Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials

Giblin, Kaplan, Somers, Le Roux, Hunter, Wu, Lalonde, Ahmad, Bethel Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials Diabetes, Obesity and Metabolism

Novel GLP-1-Based Medications for Type 2 Diabetes and Obesity

Son JW, le Roux CW, Blüher M, Nauck MA, Lim S. Novel GLP-1-Based Medications for Type 2 Diabetes and Obesity Endocr Rev
Insulin Resistance & Diabetes

Evolving Role of Double and Triple Therapy With GLP-1 Receptor Agonists in Obesity and Cardiovascular Disease

Sedrak P, Verma R, Verma M, Connelly KA. Evolving Role of Double and Triple Therapy With GLP-1 Receptor Agonists in Obesity and Cardiovascular Disease The Canadian Journal of Cardiology

Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation

Carolan A, Hynes-Ryan C, Agarwal SM, Bourke R, Cullen W, Gaughran F, Hahn MK, Krivoy A, Lally J, Leucht S, Lyne J, McCutcheon RA, Norton MJ, O'Connor K, Perry BI, Pillinger T, Shiers D, Siskind D, Thompson A, O'Shea D, Keating D, O'Donoghue B. Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation Schizophrenia Bulletin

ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine

Russo S, Proto L, Neto MG, Angelini G, Pezzica S, Carli F, Previti E, Caristo ME, Bove V, Chakaroun R, Roggiani S, Tremaroli V, Le Roux CW, Bornstein SR, Gastaldelli A, Boskoski I, Mingrone G. ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine Diabetes, Obesity & Metabolism

How do patients choose between obesity medications: A thematic analysis

Mondoh A, Craig H, Crotty M, Contreras F, le Roux CW. How do patients choose between obesity medications: A thematic analysis Obes Pillars

GPs’ perspectives on GLP-1RAs for obesity management: a qualitative study in England

Keating S, Wild C, Scragg J, Dixon S, Treadwell JS, Hinton L, Jebb S. GPs’ perspectives on GLP-1RAs for obesity management: a qualitative study in England Br J Gen Pract

International Federation for the Surgery of Obesity statement on metabolic bariatric surgery after pharmacotherapy-induced weight loss in clinical obesity

Cohen RV, Prager G, le Roux CW, Lingvay I, Salminen P. International Federation for the Surgery of Obesity statement on metabolic bariatric surgery after pharmacotherapy-induced weight loss in clinical obesity Lancet Diabetes Endocrinol

Digital Clinicians Performing Obesity Medication Self-Injection Education: Feasibility Randomized Controlled Trial

Coleman S, Lynch C, Worlikar H, Kelly E, Loveys K, Simpkin AJ, Walsh JC, Broadbent E, Finucane FM, O' Keeffe D. Digital Clinicians Performing Obesity Medication Self-Injection Education: Feasibility Randomized Controlled Trial JMIR Diabetes

What will the impact be of use of tirzepatide in patients with obstructive sleep apnea (OSA)?

Pack A, Grunstein R, Mokhlesi B, Ryan S, Schwab R, Gozal D. What will the impact be of use of tirzepatide in patients with obstructive sleep apnea (OSA)? Sleep

Older posts

Page1 Page2 … Page25 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2026 ASOI